Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Bioengineering and Biotechnology|August 27, 2024
Development of a high-speed imaging system for real time evaluation and monitoring of cardiac engineered tissuesAntoine Belzil, Roselle Gélinas, Philippe Comtois
Cardiovascular Drugs and Therapy|February 7, 2008
Medium-chain fatty acids as metabolic therapy in cardiac diseaseFrançois Labarthe, Roselle Gélinas, Christine Des Rosiers
The Canadian Journal of Cardiology|September 2, 2019
Molecular Autopsy Implicates Primary Carnitine Deficiency in Sudden Unexplained Death and Reversible Short QT SyndromeRoselle Gélinas, Emma Leach, Gabriella Horvath, et al.
Biochimica Et Biophysica Acta|August 22, 2016
O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?Florence Mailleux, Roselle Gélinas, Christophe Beauloye, et al.
Methods in Enzymology|September 12, 2015
Metabolic Tracing Using Stable Isotope-Labeled Substrates and Mass Spectrometry in the Perfused Mouse HeartMatthieu Ruiz, Roselle Gélinas, Fanny Vaillant, et al.
Frontiers in Endocrinology|October 2, 2018
AMP-Activated Protein Kinase and O-GlcNAcylation, Two Partners Tightly Connected to Regulate Key Cellular ProcessesRoselle Gélinas, Justine Dontaine, Sandrine Horman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 29, 2008
Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse heartsRoselle Gélinas, François Labarthe, Bertrand Bouchard, et al.
Frontiers in Genetics|May 6, 2024
Human induced pluripotent stem cells (hiPSCs) derived cells reflect tissue specificity found in patients with Leigh syndrome French Canadian variant (LSFC)Roselle Gélinas, Chloé Lévesque, Julie Thompson Legault, et al.
Heart Rhythm|February 28, 2016
Reduction in Na(+) current by angiotensin II is mediated by PKCα in mouse and human-induced pluripotent stem cell-derived cardiomyocytesSophie Mathieu, Nabil El Khoury, Katy Rivard, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 25, 2011
Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working heartsBenjamin Lauzier, Fanny Vaillant, Roselle Gélinas, et al.
Pageof 3